ZILERAN

DEAD

Serial Number

77905797

Owner

VALEANT INTERNATIONAL BERMUDA

Attorney

Christopher L. Graff

Filing Date

Jan 6, 2010

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

ZILERAN Trademark

Serial Number: 77905797

ZILERAN is a trademark filed by VALEANT INTERNATIONAL BERMUDA on January 6, 2010. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

VALEANT INTERNATIONAL BERMUDA (64 trademarks)

NEW VENTURE HOUSE
PEMBROKE HM05 , BM

Entity Type: 03

BIOVAIL LABORATORIES INTERNATIONAL SRL (42 trademarks)

WELCHES
CHRIST CHURCH BB17154 , BB

Entity Type: 99

Legal Representation

Attorney of Record

Christopher L. Graff

1,326 trademarks filed View all →

Correspondence Address

Christopher L. Graff Pirkey Barber PLLC

600 Congress Avenue, Suite 2120

Austin, TX 78701

UNITED STATES

Trademark Details

Filing Date

January 6, 2010

Registration Date

Not Registered

Published for Opposition

August 5, 2014

Goods & Services

Pharmaceutical preparations for the treatment of disorders, diseases, conditions and ailments, namely, eye drops, ophthalmic preparations, and pharmaceutical preparations for the treatment of eye diseases and the treatment of ocular disorders; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of disorders, diseases, conditions, and ailments of the central nervous system; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Parkinson's disease; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Huntington's disease; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of amyotrophic lateral sclerosis; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Alzheimer's disease; Pharmaceutical preparations and substances for the prevention, treatment and alleviation of Tourette Syndrome; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of epilepsy; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of multiple sclerosis; pharmaceutical preparations and substances for the treatment of depression, depressive disorders and mental illnesses; antidepressants; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of anxiety; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of pain; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of disorders, diseases, conditions, and ailments of the cardiovascular system; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of cardiopulmonary disorders, diseases, conditions, and ailments; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of disorders, diseases, conditions, and ailments of the circulatory system; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of hypertension, angina, high blood pressure, heart failure and ventricular dysfunction; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of metabolic disorders, diseases, conditions, and ailments; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of diabetes; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of viral and infectious diseases

Filing History

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Apr 16, 2025 ASCK

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED

May 2, 2016 MAB6

ABANDONMENT - NO USE STATEMENT FILED

May 2, 2016 ABN6

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 3, 2016 TCCA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 29, 2015 EXRA

SOU EXTENSION 2 GRANTED

Sep 28, 2015 EX2G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Sep 25, 2015 AITU

SOU EXTENSION 2 FILED

Sep 18, 2015 EXT2

SOU TEAS EXTENSION RECEIVED

Sep 18, 2015 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 1, 2015 EXRA

SOU EXTENSION 1 GRANTED

Mar 30, 2015 EX1G

SOU EXTENSION 1 FILED

Mar 30, 2015 EXT1

SOU TEAS EXTENSION RECEIVED

Mar 30, 2015 EEXT

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Jan 21, 2015 ASCK

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 30, 2014 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 5, 2014 NPUB

PUBLISHED FOR OPPOSITION

Aug 5, 2014 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 16, 2014 NONP

LAW OFFICE PUBLICATION REVIEW COMPLETED

Jun 28, 2014 PREV

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 23, 2014 CNSA

EXAMINER'S AMENDMENT ENTERED

Jun 20, 2014 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jun 20, 2014 GNEN

EXAMINERS AMENDMENT E-MAILED

Jun 20, 2014 GNEA

EXAMINERS AMENDMENT -WRITTEN

Jun 20, 2014 CNEA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 19, 2014 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 19, 2014 CRFA

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Jun 12, 2014 ERSI

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jan 22, 2014 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jan 22, 2014 REAP

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

Dec 12, 2013 GNS2

INQUIRY TO SUSPENSION E-MAILED

Dec 12, 2013 GNSI

SUSPENSION INQUIRY WRITTEN

Dec 12, 2013 CNSI

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

Nov 21, 2013 RCCK

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

May 20, 2013 GNS3

LETTER OF SUSPENSION E-MAILED

May 20, 2013 GNSL

SUSPENSION LETTER WRITTEN

May 20, 2013 CNSL

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 29, 2013 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 29, 2013 CRFA

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Apr 20, 2013 ERSI

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

Oct 29, 2012 GNS2

INQUIRY TO SUSPENSION E-MAILED

Oct 29, 2012 GNSI

SUSPENSION INQUIRY WRITTEN

Oct 29, 2012 CNSI

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Aug 1, 2012 ASCK

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Apr 11, 2012 GNS3

LETTER OF SUSPENSION E-MAILED

Apr 11, 2012 GNSL

SUSPENSION LETTER WRITTEN

Apr 11, 2012 CNSL

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 23, 2012 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 23, 2012 CRFA

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Mar 12, 2012 ERSI

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

Sep 15, 2011 GNS2

INQUIRY TO SUSPENSION E-MAILED

Sep 15, 2011 GNSI

SUSPENSION INQUIRY WRITTEN

Sep 15, 2011 CNSI

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

May 11, 2011 RCSC

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

Apr 28, 2011 RCCK

ASSIGNED TO LIE

Apr 22, 2011 ALIE

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Apr 6, 2011 ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Mar 23, 2011 ASCK

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Oct 19, 2010 GNS3

LETTER OF SUSPENSION E-MAILED

Oct 19, 2010 GNSL

SUSPENSION LETTER WRITTEN

Oct 19, 2010 CNSL

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 1, 2010 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 1, 2010 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 1, 2010 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 6, 2010 GNRN

NON-FINAL ACTION E-MAILED

Apr 6, 2010 GNRT

NON-FINAL ACTION WRITTEN

Apr 6, 2010 CNRT

ASSIGNED TO EXAMINER

Mar 30, 2010 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 11, 2010 NWOS

NEW APPLICATION ENTERED

Jan 9, 2010 NWAP

Related Trademarks

More from this Owner

RETIN-A

SCULPTRA AESTHETIC INJECTABLE POLY-L-LACTIC ACID STIMULATES COLAGEN FOR A NATURAL LOOK

CICABIAFINE

More in Same Class